PA
GILD icon

Probity Advisors’s Gilead Sciences GILD Stock Holding History

Probity Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
12,128
+107
+0.9% +$14.1K 0.22% 81
2026
Q1 		$1.68M Sell
12,021
-419
-3% -$58.7K 0.27% 70
2025
Q4 		$1.53M Sell
12,440
-653
-5% -$79.4K 0.24% 75
2025
Q3 		$1.45M Sell
13,093
-423
-3% -$48.1K 0.24% 74
2025
Q2 		$1.5M Sell
13,516
-390
-3% -$41.5K 0.26% 67
2025
Q1 		$1.56M Sell
13,906
-545
-4% -$56.2K 0.3% 63
2024
Q4 		$1.33M Sell
14,451
-751
-5% -$67.6K 0.26% 66
2024
Q3 		$1.27M Buy
15,202
+1,496
+11% +$114K 0.24% 76
2024
Q2 		$940K Buy
13,706
+2,222
+19% +$148K 0.19% 95
2024
Q1 		$841K Sell
11,484
-171
-1% -$13.1K 0.17% 104
2023
Q4 		$944K Buy
11,655
+1,387
+14% +$108K 0.21% 96
2023
Q3 		$769K Buy
10,268
+775
+8% +$59.6K 0.18% 86
2023
Q2 		$732K Buy
+9,493
New +$757K 0.16% 93
2022
Q4 		$775K Sell
9,026
-222
-2% -$17.6K 0.18% 87
2022
Q3 		$571K Sell
9,248
-1,372
-13% -$86.5K 0.14% 96
2022
Q2 		$656K Buy
10,620
+183
+2% +$11.3K 0.15% 95
2022
Q1 		$620K Sell
10,437
-156
-1% -$9.97K 0.13% 110
2021
Q4 		$769K Buy
10,593
+507
+5% +$34.9K 0.15% 108
2021
Q3 		$705K Buy
10,086
+696
+7% +$48.9K 0.15% 109
2021
Q2 		$647K Buy
9,390
+1,477
+19% +$98.6K 0.14% 117
2021
Q1 		$511K Buy
+7,913
New +$510K 0.11% 125
2020
Q3 		$309K Buy
4,894
+972
+25% +$67.4K 0.09% 144
2020
Q2 		$302K Buy
+3,922
New +$301K 0.09% 147

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Probity Advisors's GILD Position: Q2 2026 in Review

Probity Advisors increased its Gilead Sciences (GILD) stake by 0.89% in Q2 2026, buying an estimated $14.1K and bringing the position to 12,128 shares worth $1.53M. The position accounts for 0.22% of the portfolio, ranked #81.

Probity Advisors first reported a position in GILD in Q2 2020 and has held it in 23 quarters since. The position peaked at $1.68M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Probity Advisors held 12,128 shares of Gilead Sciences worth $1.53M as of Q2 2026.
  • Probity Advisors bought 107 Gilead Sciences shares in Q2 2026, an estimated $14.1K.
  • Gilead Sciences made up 0.22% of Probity Advisors's portfolio in Q2 2026, its #81 holding.
  • Probity Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 23 quarters since.
  • Probity Advisors's Gilead Sciences position peaked at $1.68M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Probity Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.